IL77242A - Hexahydroindan-2,2-diphosphonic acid derivatives and pharmaceutical compositions containing them - Google Patents
Hexahydroindan-2,2-diphosphonic acid derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL77242A IL77242A IL77242A IL7724285A IL77242A IL 77242 A IL77242 A IL 77242A IL 77242 A IL77242 A IL 77242A IL 7724285 A IL7724285 A IL 7724285A IL 77242 A IL77242 A IL 77242A
- Authority
- IL
- Israel
- Prior art keywords
- diphosphonic acid
- pharmaceutical compositions
- compositions containing
- hexahydroindan
- acid derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- XOHHVAJIJMPTME-UHFFFAOYSA-N (2-phosphono-1,3,3a,4,5,6,7,7a-octahydroinden-2-yl)phosphonic acid Chemical class C1CCCC2CC(P(O)(=O)O)(P(O)(O)=O)CC21 XOHHVAJIJMPTME-UHFFFAOYSA-N 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000004060 metabolic process Effects 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic diphosphonic acid compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3843—Polyphosphonic acids containing no further substituents than -PO3H2 groups
- C07F9/3852—Cycloaliphatic derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3856—Polyphosphonic acids containing halogen or nitro(so) substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL9151085A IL91510A (en) | 1984-12-21 | 1985-12-05 | Dihydro-1(or 2-)-pyrindine-6,6-diphosphonic acids and pharmaceutical compositions containing them |
| IL9151185A IL91511A (en) | 1984-12-21 | 1985-12-05 | Indane-2,2-diphosphonic acids and pharmaceutical compositions containing them |
| IL9150985A IL91509A (en) | 1984-12-21 | 1985-12-05 | Cyclic diphosphonic acids and pharmaceutical compositions comprising them |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/684,544 US4687768A (en) | 1984-12-21 | 1984-12-21 | Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL77242A true IL77242A (en) | 1991-06-10 |
Family
ID=24748496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL77242A IL77242A (en) | 1984-12-21 | 1985-12-05 | Hexahydroindan-2,2-diphosphonic acid derivatives and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4687768A (xx) |
| EP (3) | EP0189662B1 (xx) |
| JP (3) | JPH0699456B2 (xx) |
| AT (3) | ATE79628T1 (xx) |
| AU (1) | AU583873B2 (xx) |
| CA (1) | CA1279872C (xx) |
| DE (3) | DE3586543T2 (xx) |
| DK (1) | DK173943B1 (xx) |
| ES (1) | ES8704958A1 (xx) |
| IE (1) | IE58272B1 (xx) |
| IL (1) | IL77242A (xx) |
| NZ (1) | NZ214650A (xx) |
| PH (2) | PH23500A (xx) |
| ZA (1) | ZA859361B (xx) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| US4902679A (en) * | 1985-12-13 | 1990-02-20 | Norwich Eaton Pharmaceuticals, Inc. | Methods of treating diseases with certain geminal diphosphonates |
| GB8618259D0 (en) * | 1986-07-25 | 1986-09-03 | Leo Pharm Prod Ltd | Pharmaceutical compositions |
| US4868164A (en) * | 1986-12-19 | 1989-09-19 | Norwich Eaton Pharmaceuticals, Inc. | Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| US4963681A (en) * | 1987-07-06 | 1990-10-16 | Norwich Eaton Pharmaceuticals, Inc. | Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
| DE3822650A1 (de) * | 1988-07-05 | 1990-02-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| EP0466730B1 (en) * | 1989-04-03 | 1993-07-21 | The Upjohn Company | Geminal bisphosphonic acids and derivatives as anti-arthritic agents |
| US5220021A (en) * | 1989-04-03 | 1993-06-15 | The Upjohn Company | Geminal bisphosphonic acids and derivatives as anti-arthritic agents |
| US5139786A (en) * | 1989-07-07 | 1992-08-18 | Ciba-Geigy Corporation | Topical formulations |
| MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| US5324519A (en) * | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| US5487897A (en) | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| PT95286A (pt) * | 1989-09-14 | 1991-05-22 | Symphar Sa | Processo de preparacao de derivados de gem-difosfonato, substituidos por naftaleno e por tetra-hidronaftaleno e de composicoes farmaceuticas que os contem |
| AU663394B2 (en) * | 1992-05-29 | 1995-10-05 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate for treating abnormal calcium and phosphate metabolism |
| ATE195317T1 (de) * | 1992-05-29 | 2000-08-15 | Procter & Gamble Pharma | Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus |
| HUT69731A (en) * | 1992-05-29 | 1995-09-28 | Procter & Gamble Pharma | Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| US5753634A (en) * | 1992-05-29 | 1998-05-19 | The Procter & Gamble Company | Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism |
| DK0646119T3 (da) * | 1992-05-29 | 1998-12-14 | Procter & Gamble Pharma | Phosphonatforbindelser indeholdende kvaternært nitrogen til behandling af unormalt calcium- og phosphatstofskifte samt tan |
| US5391743A (en) * | 1992-05-29 | 1995-02-21 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
| US5763611A (en) * | 1992-05-29 | 1998-06-09 | The Procter & Gamble Company | Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| CA2138366C (en) * | 1992-06-30 | 1998-09-22 | Kristine Hovancik | Methods for the treatment of arthritis using phosphonates and nsaids |
| US5591730A (en) * | 1993-10-12 | 1997-01-07 | The Regents Of The University Of California | Inhibition of urinary calculi growth |
| US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
| US5753633A (en) * | 1997-04-11 | 1998-05-19 | Colgate-Palmolive Company | Method of inhibiting bone resorption |
| US6187329B1 (en) | 1997-12-23 | 2001-02-13 | Board Of Regents Of The University Of Texas System | Variable permeability bone implants, methods for their preparation and use |
| US6255359B1 (en) | 1997-12-23 | 2001-07-03 | Board Of Regents Of The University Of Texas System | Permeable compositions and methods for their preparation |
| ES2359973T3 (es) * | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas. |
| US7128927B1 (en) | 1998-04-14 | 2006-10-31 | Qlt Usa, Inc. | Emulsions for in-situ delivery systems |
| US8226598B2 (en) * | 1999-09-24 | 2012-07-24 | Tolmar Therapeutics, Inc. | Coupling syringe system and methods for obtaining a mixed composition |
| EP1248790A1 (en) * | 1999-12-17 | 2002-10-16 | Ariad Pharmaceuticals, Inc. | Proton pump inhibitors |
| WO2001044258A1 (en) * | 1999-12-17 | 2001-06-21 | Ariad Pharmaceuticals, Inc. | Novel heterocycles |
| US7115589B2 (en) | 1999-12-17 | 2006-10-03 | Ariad Pharmaceuticals, Inc. | Purine derivatives |
| TW200413381A (en) | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| US20050065171A1 (en) * | 2003-06-25 | 2005-03-24 | Shakespeare William C. | Substituted purine derivatives |
| US8362086B2 (en) | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
| US7781418B2 (en) * | 2006-12-14 | 2010-08-24 | Isis Innovation Ltd. | Composition for treating bone disorders |
| US20090234024A1 (en) | 2008-02-04 | 2009-09-17 | Hooman Shadnia | Estrogenic compounds, process for their production and pharmaceutical uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3683080A (en) * | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US3988433A (en) * | 1973-08-10 | 1976-10-26 | The Procter & Gamble Company | Oral compositions for preventing or removing stains from teeth |
| US3988443A (en) * | 1973-08-27 | 1976-10-26 | Henkel & Cie G.M.B.H. | Azacycloalkane-2,2-diphosphonic acids |
| DE2343147C2 (de) * | 1973-08-27 | 1982-06-09 | Henkel KGaA, 4000 Düsseldorf | Pyrrolidon-5,5-diphosphonsäuren, deren wasserlösliche Salze, und Verfahren zu ihrer Herstellung |
| DE2343196C3 (de) * | 1973-08-27 | 1980-01-10 | Henkel Kgaa, 4000 Duesseldorf | Aiacycloalkan-2^-diphosphonsäuren oder deren wasserlösliche Salze |
| US4034086A (en) * | 1973-08-27 | 1977-07-05 | Henkel & Cie G.M.B.H. | Pyrrolidone-5,5-diphosphonic acids |
| DE2543349C2 (de) * | 1975-09-29 | 1984-05-10 | Henkel KGaA, 4000 Düsseldorf | Preaparate zur herstellung von99m technetium-radiagnostica |
| SE7612534L (sv) * | 1975-12-01 | 1977-06-02 | Henkel & Cie Gmbh | Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning |
| US4330537A (en) * | 1977-12-07 | 1982-05-18 | The Procter & Gamble Company | Compositions for inhibiting mobilization of calcium phosphate in animal tissue |
-
1984
- 1984-12-21 US US06/684,544 patent/US4687768A/en not_active Expired - Lifetime
-
1985
- 1985-12-05 IL IL77242A patent/IL77242A/xx not_active IP Right Cessation
- 1985-12-06 ZA ZA859361A patent/ZA859361B/xx unknown
- 1985-12-16 EP EP85309142A patent/EP0189662B1/en not_active Expired
- 1985-12-16 DE DE8888114437T patent/DE3586543T2/de not_active Expired - Fee Related
- 1985-12-16 EP EP88114436A patent/EP0304961B1/en not_active Expired - Lifetime
- 1985-12-16 DE DE8585309142T patent/DE3572822D1/de not_active Expired
- 1985-12-16 AT AT88114437T patent/ATE79628T1/de not_active IP Right Cessation
- 1985-12-16 DE DE88114436T patent/DE3587527T2/de not_active Expired - Fee Related
- 1985-12-16 EP EP88114437A patent/EP0304962B1/en not_active Expired - Lifetime
- 1985-12-16 AT AT88114436T patent/ATE92932T1/de not_active IP Right Cessation
- 1985-12-16 AT AT85309142T patent/ATE46167T1/de not_active IP Right Cessation
- 1985-12-17 PH PH33193A patent/PH23500A/en unknown
- 1985-12-19 CA CA000498175A patent/CA1279872C/en not_active Expired - Fee Related
- 1985-12-20 NZ NZ214650A patent/NZ214650A/xx unknown
- 1985-12-20 AU AU51538/85A patent/AU583873B2/en not_active Ceased
- 1985-12-20 DK DK198505995A patent/DK173943B1/da not_active IP Right Cessation
- 1985-12-20 IE IE328585A patent/IE58272B1/en not_active IP Right Cessation
- 1985-12-20 ES ES550243A patent/ES8704958A1/es not_active Expired
- 1985-12-21 JP JP60289125A patent/JPH0699456B2/ja not_active Expired - Fee Related
-
1987
- 1987-08-14 US US07/085,906 patent/US4939131A/en not_active Expired - Lifetime
-
1988
- 1988-11-09 PH PH37782A patent/PH25769A/en unknown
-
1994
- 1994-05-30 JP JP6117250A patent/JPH07113037B2/ja not_active Expired - Fee Related
- 1994-05-30 JP JP6117242A patent/JP2680264B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL77242A (en) | Hexahydroindan-2,2-diphosphonic acid derivatives and pharmaceutical compositions containing them | |
| IE853286L (en) | Pharmaceutical compositions containing geminal¹diphosphonates | |
| NZ225274A (en) | Methylene phosphonoalkylphosphinic acid derivatives and pharmaceutical compositions | |
| IL84660A0 (en) | Bicyclic diphosphonate compounds and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |